Showing results (641-650 of 655) with videos related to

Sort By:
Pageof 66
Circulation. Population Health and Outcomes|January 19, 2026
Estimating the Placebo Effect on Patient-Reported Outcomes in Sham-controlled Device Trials: Insights from REDUCE LAP-HF IIAndrew A Girard, Uma Mylavarapu, Jan Komtebedde, et al.
The Annals of Thoracic Surgery|December 18, 2024
Five- Year Outcomes in Low-Risk Patients Undergoing Surgery in the PARTNER 3 TrialVinod H Thourani, Martin B Leon, Raj Makkar, et al.
Journal of the American College of Cardiology|March 5, 2021
Outcomes 2 Years After Transcatheter Aortic Valve Replacement in Patients at Low Surgical RiskMartin B Leon, Michael J Mack, Rebecca T Hahn, et al.
Journal of the American College of Cardiology|October 16, 2020
Structural Deterioration of Transcatheter Versus Surgical Aortic Valve Bioprostheses in the PARTNER-2 TrialPhilippe Pibarot, Julien Ternacle, Wael A Jaber, et al.
JACC. Cardiovascular Imaging|April 17, 2025
5-Year Echocardiographic Results of Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk PatientsRebecca T Hahn, Julien Ternacle, Iria Silva, et al.
JACC. Cardiovascular Interventions|July 10, 2025
Incidence, Predictors, and Management of Conduction Disturbances After Transcatheter Tricuspid Valve Replacement: The TRIPLACE RegistryAndrea Scotti, Rishi Puri, Matteo Sturla, et al.
Circulation|April 11, 2020
Echocardiographic Results of Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients: The PARTNER 3 TrialPhilippe Pibarot, Erwan Salaun, Abdellaziz Dahou, et al.
JACC. Clinical Electrophysiology|January 23, 2026
Transcatheter Tricuspid Valve Replacement in Patients With Cardiac Implantable Electronic Device Leads: The TRIPLACE RegistryBryan P Traynor, Andrea Scotti, Rishi Puri, et al.
JACC. Cardiovascular Interventions|December 30, 2019
Mid-Term Outcomes of Transcatheter Aortic Valve Replacement in Extremely Large Annuli With Edwards SAPIEN 3 ValveAditya Sengupta, Syed Zaid, Norihiko Kamioka, et al.
JAMA Cardiology|June 24, 2026
Seven-Year Valve Durability With Transcatheter or Surgical Aortic Valve Replacement: An Ad Hoc Analysis of the PARTNER 3 Randomized Clinical TrialJulien Ternacle, Rebecca T Hahn, Iria Silva, et al.
Pageof 66